{
    "medicine_id": "35d132dc4555f83ec4c54216a3259b3acee9b0f2",
    "platform_id": "DB00596",
    "metadata": {
        "name": "Bryhali 0 1 mg 1g Lotion",
        "composition": "0 1 mg 1g Ulobetasol",
        "clinical_particulars": {
            "therapeutic_indications": "Ulobetasol cream and ointment are indicated in the treatment of inflammatory and pruritic corticosteroid responsive dermatoses L15047 Ulobetasol lotion is indicated in the treatment of plaque psoriasis L15052",
            "contraindications": {
                "disease": "Data regarding acute overdoses of glucocorticoids are rare L15047 L15052 Chronic high doses of glucocorticoids can lead to the development of cataract glaucoma hypertension water retention hyperlipidemia peptic ulcer pancreatitis myopathy osteoporosis mood changes psychosis dermal atrophy allergy acne hypertrichosis immune suppression decreased resistance to infection moon face hyperglycemia hypocalcemia hypophosphatemia metabolic acidosis growth suppression and secondary adrenal insufficiency A188405 Overdose may be treated by adjusting the dose or stopping the corticosteroid as well as initiating symptomatic and supportive treatment A188405 L15102",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Corticosteroids bind to the glucocorticoid receptor inhibiting pro inflammatory signals and promoting anti inflammatory signals A187463 Ulobetasol has a moderate duration of action as it is applied once or twice daily L15047 L15052 Corticosteroids have a wide therapeutic window as patients may require doses that are multiples of what the body naturally produces A187463 Patients taking corticosteroids should be counselled regarding the risk of hypothalamic pituitary adrenal axis suppression and increased susceptibility to infections A187463",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00072",
                        "description": "Trastuzumab may increase the neutropenic activities of Ulobetasol"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "Tacrolimus may increase the immunosuppressive activities of Ulobetasol"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The risk or severity of hypertension can be increased when Ulobetasol is combined with Phenylephrine"
                    },
                    {
                        "drugbank-id": "DB00357",
                        "description": "The therapeutic efficacy of Ulobetasol can be decreased when used in combination with Aminoglutethimide"
                    },
                    {
                        "drugbank-id": "DB00030",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin human"
                    },
                    {
                        "drugbank-id": "DB00046",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin lispro"
                    },
                    {
                        "drugbank-id": "DB00047",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin glargine"
                    },
                    {
                        "drugbank-id": "DB00071",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin pork"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Troglitazone"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Glimepiride"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00284",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Acarbose"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Metformin"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Sulfadiazine"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00414",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Acetohexamide"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00491",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Miglitol"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Chlorpropamide"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Nateglinide"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Tolazamide"
                    },
                    {
                        "drugbank-id": "DB00912",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Repaglinide"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Phenformin"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Sulfamethoxazole"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Glyburide"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Glipizide"
                    },
                    {
                        "drugbank-id": "DB01120",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Gliclazide"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Tolbutamide"
                    },
                    {
                        "drugbank-id": "DB01132",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Pioglitazone"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB01251",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Gliquidone"
                    },
                    {
                        "drugbank-id": "DB01252",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Mitiglinide"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Sitagliptin"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Sunitinib"
                    },
                    {
                        "drugbank-id": "DB01276",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Exenatide"
                    },
                    {
                        "drugbank-id": "DB01277",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Mecasermin"
                    },
                    {
                        "drugbank-id": "DB01278",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Pramlintide"
                    },
                    {
                        "drugbank-id": "DB01289",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Glisoxepide"
                    },
                    {
                        "drugbank-id": "DB01306",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin aspart"
                    },
                    {
                        "drugbank-id": "DB01307",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin detemir"
                    },
                    {
                        "drugbank-id": "DB01309",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin glulisine"
                    },
                    {
                        "drugbank-id": "DB01382",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Glymidine"
                    },
                    {
                        "drugbank-id": "DB01700",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with AICA ribonucleotide"
                    },
                    {
                        "drugbank-id": "DB04830",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Buformin"
                    },
                    {
                        "drugbank-id": "DB04876",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Vildagliptin"
                    },
                    {
                        "drugbank-id": "DB04878",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Voglibose"
                    },
                    {
                        "drugbank-id": "DB05115",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with NN344"
                    },
                    {
                        "drugbank-id": "DB05819",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with NBI 6024"
                    },
                    {
                        "drugbank-id": "DB06011",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with AMG 222"
                    },
                    {
                        "drugbank-id": "DB06127",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Bisegliptin"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Alogliptin"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Dapagliflozin"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Saxagliptin"
                    },
                    {
                        "drugbank-id": "DB06655",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Liraglutide"
                    },
                    {
                        "drugbank-id": "DB08382",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Gosogliptin"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Linagliptin"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08962",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Glibornuride"
                    },
                    {
                        "drugbank-id": "DB09022",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Benfluorex"
                    },
                    {
                        "drugbank-id": "DB09038",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Empagliflozin"
                    },
                    {
                        "drugbank-id": "DB09043",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Albiglutide"
                    },
                    {
                        "drugbank-id": "DB09045",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Dulaglutide"
                    },
                    {
                        "drugbank-id": "DB09198",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Lobeglitazone"
                    },
                    {
                        "drugbank-id": "DB09199",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Netoglitazone"
                    },
                    {
                        "drugbank-id": "DB09200",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Rivoglitazone"
                    },
                    {
                        "drugbank-id": "DB09201",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Ciglitazone"
                    },
                    {
                        "drugbank-id": "DB09265",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Lixisenatide"
                    },
                    {
                        "drugbank-id": "DB09456",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin beef"
                    },
                    {
                        "drugbank-id": "DB09564",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin degludec"
                    },
                    {
                        "drugbank-id": "DB11567",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin peglispro"
                    },
                    {
                        "drugbank-id": "DB11568",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin tregopil"
                    },
                    {
                        "drugbank-id": "DB11698",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Ipragliflozin"
                    },
                    {
                        "drugbank-id": "DB11723",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Dutogliptin"
                    },
                    {
                        "drugbank-id": "DB11780",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Allicin"
                    },
                    {
                        "drugbank-id": "DB11824",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Tofogliflozin"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Ertugliflozin"
                    },
                    {
                        "drugbank-id": "DB11898",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with 2 4 thiazolidinedione"
                    },
                    {
                        "drugbank-id": "DB11950",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Teneligliptin"
                    },
                    {
                        "drugbank-id": "DB11992",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Omarigliptin"
                    },
                    {
                        "drugbank-id": "DB12268",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Carmegliptin"
                    },
                    {
                        "drugbank-id": "DB12412",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Gemigliptin"
                    },
                    {
                        "drugbank-id": "DB12417",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Anagliptin"
                    },
                    {
                        "drugbank-id": "DB12625",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Evogliptin"
                    },
                    {
                        "drugbank-id": "DB12713",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Sotagliflozin"
                    },
                    {
                        "drugbank-id": "DB12781",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Balaglitazone"
                    },
                    {
                        "drugbank-id": "DB12935",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Remogliflozin etabonate"
                    },
                    {
                        "drugbank-id": "DB13406",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Carbutamide"
                    },
                    {
                        "drugbank-id": "DB13446",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Guar gum"
                    },
                    {
                        "drugbank-id": "DB13675",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Metahexamide"
                    },
                    {
                        "drugbank-id": "DB13928",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Semaglutide"
                    },
                    {
                        "drugbank-id": "DB14027",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Taspoglutide"
                    },
                    {
                        "drugbank-id": "DB14035",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Englitazone"
                    },
                    {
                        "drugbank-id": "DB15171",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Tirzepatide"
                    },
                    {
                        "drugbank-id": "DB15217",
                        "description": "The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Gastric inhibitory polypeptide"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The serum concentration of Isoniazid can be decreased when it is combined with Ulobetasol"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The risk or severity of adverse effects can be increased when Ulobetasol is combined with Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The risk or severity of adverse effects can be increased when Ulobetasol is combined with Digoxin"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "The risk or severity of adverse effects can be increased when Ulobetasol is combined with Acetyldigitoxin"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "The risk or severity of adverse effects can be increased when Ulobetasol is combined with Deslanoside"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of adverse effects can be increased when Ulobetasol is combined with Digitoxin"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The risk or severity of adverse effects can be increased when Ulobetasol is combined with Metildigoxin"
                    },
                    {
                        "drugbank-id": "DB13467",
                        "description": "The risk or severity of adverse effects can be increased when Ulobetasol is combined with Lanatoside C"
                    },
                    {
                        "drugbank-id": "DB13537",
                        "description": "The risk or severity of adverse effects can be increased when Ulobetasol is combined with Gitoformate"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of adverse effects can be increased when Ulobetasol is combined with Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The serum concentration of Ulobetasol can be decreased when it is combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The serum concentration of Ulobetasol can be decreased when it is combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Ulobetasol"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Ulobetasol can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The risk or severity of electrolyte imbalance can be increased when Ulobetasol is combined with Methyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The risk or severity of electrolyte imbalance can be increased when Ulobetasol is combined with Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The risk or severity of electrolyte imbalance can be increased when Ulobetasol is combined with Benzthiazide"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "The risk or severity of electrolyte imbalance can be increased when Ulobetasol is combined with Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The risk or severity of electrolyte imbalance can be increased when Ulobetasol is combined with Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The risk or severity of electrolyte imbalance can be increased when Ulobetasol is combined with Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of electrolyte imbalance can be increased when Ulobetasol is combined with Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The risk or severity of electrolyte imbalance can be increased when Ulobetasol is combined with Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The risk or severity of electrolyte imbalance can be increased when Ulobetasol is combined with Polythiazide"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "The risk or severity of electrolyte imbalance can be increased when Ulobetasol is combined with Mebutizide"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The risk or severity of electrolyte imbalance can be increased when Ulobetasol is combined with Cyclopenthiazide"
                    },
                    {
                        "drugbank-id": "DB12530",
                        "description": "The risk or severity of infection can be increased when Ulobetasol is combined with Inebilizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}